CN1216623C - Blood pressure reducing and stabiliaing Chinese medicine and its prepn - Google Patents
Blood pressure reducing and stabiliaing Chinese medicine and its prepn Download PDFInfo
- Publication number
- CN1216623C CN1216623C CN 02132552 CN02132552A CN1216623C CN 1216623 C CN1216623 C CN 1216623C CN 02132552 CN02132552 CN 02132552 CN 02132552 A CN02132552 A CN 02132552A CN 1216623 C CN1216623 C CN 1216623C
- Authority
- CN
- China
- Prior art keywords
- radix
- blood pressure
- chinese medicine
- distilled water
- adjuvant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a blood pressure reducing and stabilizing traditional Chinese medicine for treating hypertension, which is mainly prepared from the following components according to weight proportion: main materials: 6 to 30g of kendir, 5 to 20g of Chinese angelica root, 10 to 20g of fleeceflower root, 10 to 40g of barbary wolfberry fruit and 5 to 20g of devilpepper root; auxiliary materials: 1000 to 3000g of white wine and 1200 to 3000g of distilled water. The preparation method comprises the following steps that firstly, the white wine is prepared and is held in a container; the medicines are pulverized and uniformly mixed according to the proportion, and then are filled into the container holding the white wine; the container is heated and steamed to boiling for 10 to 60 minutes; the cooked medicines are filtered, and dregs are filtered out; the distilled water is mixed with the obtained physic liquor, and then the blood pressure reducing medicinal wine is obtained. For the preparation of tablets, pills and injections, the dosage of the auxiliary materials adopts a lower limit value, and the processes of distillation and purification are added after the process of the preparation of the medicinal wine. The traditional Chinese medicine has the advantages of no toxic or side effect, no generation of drug resistance and difficult recurrence after cure. The effectual rate of the present invention reaches 94%, and the cure rate reaches 85%.
Description
Technical field: the present invention relates to a kind of blood pressure lowering, voltage stabilizing Chinese medicine and manufacture method for the treatment of high blood pressure disease, belong to pharmaceutical field.
Background technology: hypertension, the traditional Chinese medical science is divided into three types with it, i.e. excessive rising of liver-YANG, the hepatic and renal YIN deficiency, QI and blood deficiency.The medicine major part of treatment high blood pressure disease of the prior art is the dependent drug of curing the symptoms, not the disease.When taking, the kind that the patient needs often to change medicine reaches the drug-fast problem that solves.When most medicine is taken more than 3 years the patient, because the negative interaction of medicine brings new pathological changes can for each internal organs of human body.
Summary of the invention: the objective of the invention is deficiency, and provide a kind for the treatment of both the principal and secondary aspects of a disease to people at above-mentioned technology, can nourishing the liver and kidney, suppressing the hyperactive liver blood pressure lowering, cardiac stimulant blood pressure lowering, voltage stabilizing Chinese medicine and manufacture method.For achieving the above object, the present invention adopts following technical proposals: a kind of blood pressure lowering, voltage stabilizing Chinese medicine, mainly by following component and making by weight ratio:
Major ingredient:
Herba Apocyni veneti 6-30g;
Radix Angelicae Sinensis 5-20g;
Radix Polygoni Multiflori 10-20g;
Fructus Lycii 10-40g;
Radix Rauvolfiae 5-20g;
Adjuvant:
Chinese liquor 1000-3000g;
Distilled water 1200-3000g.
In said components, also can add major ingredient:
Leaf of Folium Stevlae Rebaudianae 5-45g;
Radix Ginseng 6-12g;
Concrete manufacture method is:
(1) makes Chinese liquor earlier, Chinese liquor is contained in the container;
(2) said medicine is pulverized, and packed into after by said ratio and to contain in the container of wine the medicine mixing;
(3) with container heating, steaming and decocting, boiled 10-60 minute;
(4) well-done medicine filters, the filtering medicinal residues;
(5) distilled water is mixed with medicinal liquid, make blood pressure lowering medicated wine.As to make tablet, pill, and the consumption of its adjuvant of injection adopt lower limit, after the operation of making medicated wine, increase and distill purification process, film-making again, pill.
The pharmacology of each component and function are among the present invention: Herba Apocyni veneti has the effect of clearing away liver-fire, blood pressure lowering; Radix Angelicae Sinensis has function of promoting blood circulation to disperse blood clots; Radix Polygoni Multiflori has the nourishing the liver and kidney effect; Fructus Lycii has the effect of enriching yin and nourishing kidney; Radix Rauvolfiae has hypotensive effect; Leaf of Folium Stevlae Rebaudianae has hypotensive activity; Radix Ginseng has the heart strengthening and the mind tranquilizing, qi invigorating functions.Said medicine promptly has the effect of the merit that mutual compatibility rules together, and the energy of dividing and ruling is arranged again.(1) merit of ruling together: various medicines in the prescription of the present invention all have the function of blood pressure lowering, and between every herbal medicine, have compatibility effect and can give play to maximum curative effect; (2) energy of dividing and ruling: various medicines also can be brought into play the therapeutical effect of its single medicine at all kinds respectively except general character.Be that folk prescription is arranged in the compound recipe in the prescription of this invention, compound recipe is arranged in the folk prescription, can be at the patients with hypertension of various different origins.Its manufacture method science is simple, can make various dosage forms as required, as: tablet, pill, injection and medicated wine.Take the no toxic side effect in back, do not develop immunity to drugs, 10 days each courses of treatment, can make blood pressure stabilization about 1 year after taking two courses of treatment; Can cure six courses of treatment, cures the back and be difficult for recurrence.
Specific embodiment:
Embodiment 1
A kind of blood pressure lowering, voltage stabilizing Chinese medicine, mainly by following component and making by weight ratio:
Major ingredient:
Herba Apocyni veneti 6g;
Radix Angelicae Sinensis 5g;
Radix Polygoni Multiflori 10g;
Fructus Lycii 10g;
Radix Rauvolfiae 5g;
Leaf of Folium Stevlae Rebaudianae 5g;
Radix Ginseng 6g;
Adjuvant:
Chinese liquor 1000g;
Distilled water 1200g.
Concrete manufacture method is:
(1) makes Chinese liquor, Chinese liquor is contained in the container;
(2) said medicine is pulverized, and packed into after by said ratio and to contain in the container of wine the medicine mixing;
(3) with container heating, steaming and decocting, boiled 10-60 minute;
(4) well-done medicine is filtered the filtering medicinal residues;
(5) distilled water is mixed canned with medicinal liquid, make medicated wine.
Embodiment 2
A kind of blood pressure lowering, voltage stabilizing Chinese medicine, mainly by following component and making by weight ratio:
Major ingredient:
Herba Apocyni veneti 15g;
Radix Angelicae Sinensis 6g;
Radix Polygoni Multiflori 10g;
Fructus Lycii 10g;
Radix Rauvolfiae 5g;
Leaf of Folium Stevlae Rebaudianae 12g;
Radix Ginseng 10g;
Adjuvant:
Chinese liquor 1500g;
Distilled water 1200g.
Concrete manufacture method is identical with embodiment 1.
Embodiment 3
A kind of blood pressure lowering, voltage stabilizing Chinese medicine, mainly by following component and making by weight ratio:
Major ingredient:
Herba Apocyni veneti 30g;
Radix Angelicae Sinensis 20g;
Radix Polygoni Multiflori 20g;
Fructus Lycii 40g;
Radix Rauvolfiae 20g;
Leaf of Folium Stevlae Rebaudianae 45g;
Radix Ginseng 12g;
Adjuvant:
Chinese liquor 3000g;
Distilled water 3000g.
Concrete manufacture method is identical with embodiment 1.
The preparation of above-mentioned 3 embodiment prescriptions is to be example with medicated wine, adopts lower limit as the consumption that will make tablet, pill and its adjuvant of injection, increases the distillation purification process after the operation of making medicated wine, film-making again, pill.
Through clinical be to 158 routine patient's situations of taking: male patient 59 people, year order is 57 people between 48-65 year through its obvious effective rate of 2-3 course of therapy (be 10 days each course of treatment), cure rate is 50 people; Female patient 99 people, 45-72 is 93 people through its obvious effective rate of 2-4 course of therapy (be 10 days each course of treatment) between year, cure rate is 85 people.Take total obvious effective rate through above-mentioned 158 people and reach 94%; Cure rate reaches 85%.
Claims (5)
1, a kind of blood pressure lowering, voltage stabilizing Chinese medicine, it is the major ingredient by the following weight proportioning:
Herba Apocyni veneti 6-30g;
Radix Angelicae Sinensis 5-20g;
Radix Polygoni Multiflori 10-20g;
Fructus Lycii 10-40g;
Radix Rauvolfiae 5-20g;
Leaf of Folium Stevlae Rebaudianae 5-45g;
Radix Ginseng 6-12g;
Adjuvant:
Chinese liquor 1000-3000g;
Distilled water 1200-3000g is made.
2, blood pressure lowering according to claim 1, voltage stabilizing Chinese medicine, its weight proportion is a major ingredient:
Herba Apocyni veneti 6g;
Radix Angelicae Sinensis 5g;
Radix Polygoni Multiflori 10g;
Fructus Lycii 10g;
Radix Rauvolfiae 5g;
Leaf of Folium Stevlae Rebaudianae 5g;
Radix Ginseng 6g;
Adjuvant:
Chinese liquor 1000g;
Distilled water 1200g.
3, blood pressure lowering according to claim 1, voltage stabilizing Chinese medicine, its weight proportion is a major ingredient:
Herba Apocyni veneti 15g;
Radix Angelicae Sinensis 6g;
Radix Polygoni Multiflori 10g;
Fructus Lycii 10g;
Radix Rauvolfiae 5g;
Leaf of Folium Stevlae Rebaudianae 12g;
Radix Ginseng 10g;
Adjuvant:
Chinese liquor 1500g;
Distilled water 1200g.
4, blood pressure lowering according to claim 1, voltage stabilizing Chinese medicine, its weight proportion is a major ingredient:
Herba Apocyni veneti 30g;
Radix Angelicae Sinensis 20g;
Radix Polygoni Multiflori 20g;
Fructus Lycii 40g;
Radix Rauvolfiae 20g;
Leaf of Folium Stevlae Rebaudianae 45g;
Radix Ginseng 12g;
Adjuvant:
Chinese liquor 3000g;
Distilled water 3000g.
5, according to the manufacture method of any one described blood pressure lowering of claim 1-4, voltage stabilizing Chinese medicine, it is characterized in that it as follows step carry out:
A. make Chinese liquor earlier, Chinese liquor is contained in the container;
B. major ingredient being pulverized packs into behind the mixing contains in the container of wine;
C. heating, steaming and decocting, boiled 10-60 minute;
D. remove by filter bits and get medicinal liquid;
E. distilled water is mixed with medicinal liquid, make medicated wine, adopt lower limit, after the operation of making medicated wine, increase the distillation purification process, film-making again, pill as the consumption that will make tablet, pill and its adjuvant of injection.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02132552 CN1216623C (en) | 2002-07-08 | 2002-07-08 | Blood pressure reducing and stabiliaing Chinese medicine and its prepn |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02132552 CN1216623C (en) | 2002-07-08 | 2002-07-08 | Blood pressure reducing and stabiliaing Chinese medicine and its prepn |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1387904A CN1387904A (en) | 2003-01-01 |
| CN1216623C true CN1216623C (en) | 2005-08-31 |
Family
ID=4746830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 02132552 Expired - Fee Related CN1216623C (en) | 2002-07-08 | 2002-07-08 | Blood pressure reducing and stabiliaing Chinese medicine and its prepn |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1216623C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104644741A (en) * | 2013-11-18 | 2015-05-27 | 曾正 | Traditional Chinese medicinal vinegar capable of reducing blood pressure |
| CN104083478A (en) * | 2014-07-28 | 2014-10-08 | 谭元生 | Compound traditional Chinese medicine for treating hypertension |
-
2002
- 2002-07-08 CN CN 02132552 patent/CN1216623C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1387904A (en) | 2003-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1186071C (en) | Medicines composition for treating chronic heart failure and its prepn | |
| CN1201776C (en) | Medicines composition for treating diabetes and its prepn | |
| CN1051237C (en) | Meicinal prepn. "Kexianling" for curing epilepsy | |
| CN1092314A (en) | Treatment diarrheal Chinese medicine for outer use | |
| CN1059106C (en) | Durg for curing headache and preparation technology thereof | |
| CN1216623C (en) | Blood pressure reducing and stabiliaing Chinese medicine and its prepn | |
| CN110934924A (en) | Traditional Chinese medicine bone marrow hematogenesis composition and application thereof | |
| CN1060657C (en) | Nourishing medicine for preventing and curing toxic and side effect after tumor radiotherapy and chemotherapy and preparation method | |
| CN1317315A (en) | Tendon-comfortable analgesic | |
| CN1133458C (en) | Chinese herb medicine preparation for curing prolapse of lumbar intervertebral disk | |
| CN1053363C (en) | Oral liquid of shengxueyin | |
| CN1616076A (en) | Medicine for treating cardiocerebral vascular system disease and blood supply deficiency, medicine preparing method and preparation | |
| CN1111054C (en) | Medicine for treating apoplexy and its preparing process | |
| CN1377672A (en) | Rheumatic pain killing preparation | |
| CN100336547C (en) | Medicine for treating high blood pressure disease | |
| CN1883660A (en) | Blood fat-reducing Chinese medicine and preparation method thereof | |
| CN1136939A (en) | Chinese drugs for curing hepatitis B | |
| CN1589839A (en) | Stasis transforming pain relieving particle agent and its preparation method | |
| CN1061249C (en) | Quick-acting traditional Chinese medicine for curing hepatitis B | |
| CN1132096A (en) | Chinese drug for treatment of hemiplegia | |
| CN1302639A (en) | Tendon-conditioning analgetic | |
| CN1470271A (en) | Chinese medicinal compound preparation for treating liver fibrillation disease and its preparation method | |
| CN1126558C (en) | Medicine for treating kidney damage caused by immunological disease lupus erythematosus | |
| CN1250243C (en) | Compound Chinese medical preparation for curing cardiovascular, cerebrovascular diseases and its preparing method | |
| CN1840106A (en) | Medicine for treating chronic hepatitis B and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050831 Termination date: 20140708 |
|
| EXPY | Termination of patent right or utility model |